Dabrafenib plus trametinib for biliary tract cancer

• Univadis Medical News
• Monday 19 November 2018

Results presented as a late-breaking abstract at the 30th EORTC-NCI-AACR symposium.

European doctors organisation calls for action on alcohol labelling

• Univadis Medical News
• Monday 19 November 2018

The Standing Committee for European Doctors says it believes consumers have a right to know what they are drinking.

Google to create artificial intelligence assistant for doctors

• Univadis Medical News
• Monday 19 November 2018

Plans to build upon the UK-based Streams app have been announced.

GBD 2017 study highlights: improvement in estimating risk factor exposures and relative risks

• 
• Monday 19 November 2018

The GBD 2017 comparative risk assessment includes 84 risk factors and 476 associated risk–outcome pairs

Huntington’s disease: classification need to be revised for juvenile forms

• 
• Friday 16 November 2018

A retrospective analysis of medical records of patients with juvenile Huntington’s disease and with adult-onset Huntington’s disease

Use of deep learning algorithms in medical image analysis

Deep learning helps to identify, classify, and quantify patterns in medical images

Global burden of firearm injury deaths

The study estimated firearm-related mortality from 1990-2016 for 195 countries and territories by age and by sex

ESMO 2018 Expert commentary - Treatment of advanced breast cancer: how to evaluate the benefits of clinical trials

• Oncology Conference reports
• Tuesday 30 October 2018

ESMO 2018 Expert commentary - Will CAR-T cell therapy replace allogenic transplant in chemoresistant lymphoma?

• Oncology Conference reports
• Tuesday 30 October 2018

ESMO 2018 Expert Commentary – Beyond resistance in immuno-oncology

• Oncology Conference reports
• Tuesday 30 October 2018

Resistance to immunotherapy is related to the molecular characteristics of a tumour and its microenvironment. Genetic and immune profiling of patients may help.